DMAA - NASDAQ
Drugs Made In America Acquisition Corp. Ordinary Shares
$10.60
+0.094%Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
At a Glance
Live SnapshotDrugs Made In America Acquisition Corp. Ordinary Shares Street Expectations Map
No Target Data
No analyst price targets available for dmaa.
Drugs Made In America Acquisition Corp. Ordinary Shares Forward Estimates of Revenue
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares Forward Estimates of Net Income
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares Forward Estimates of EPS
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares Forward Estimates of EBIT
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares Forward Estimates of EBITDA
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares Forward Estimates of SG&A Expense
Forward Growth Analysis
Analyst skepticism evident—carefully evaluate risks before investment decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares Insider Positioning
During the last 12 months, there has been no insider trading activity reported for DMAA.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
No buying activity
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.
Insider Participation
No insider trading activity reported from any insiders in the past year.
Related Guides
Continue your DMAA research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.